logo
  

Wells Fargo Names Steven Black Chairman With Immediate Effect, Succeeding Charles Noski

Financial services major Wells Fargo & Co. (WFC) announced Tuesday that Steven Black has been elected as chairman of Board of Directors, effective immediately.

Black succeeds Charles Noski, who has stepped down as chairman. Noski will remain as a director until he retires on September 30.

The board also appointed Wayne Hewett to serve as a member and as chair of the Governance and Nominating Committee.

Noski has served as a director since June 2019 and as chairman since March 2020. Noski previously served as chair of the board's Audit Committee and, until today, as chair of its Governance and Nominating Committee.

The newly elected chairman, who joined the board in 2020, has over 45 years of financial services experience with some of the largest financial institutions in the world. He has served as co-CEO of Bregal Investments, a private equity firm, since September 2012.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT